Dimension and Bayer join forces to develop gene therapy for Hemophilia A
Dimension Therapeutics has entered into a collaboration with Bayer HealthCare for the development and commercialization of a novel gene therapy for the treatment of hemophilia A. Dimension has been funded by Fidelity Biosciences and OrbiMed Advisors .
Join the discussion below, or Read more at PE Hub.
#1 Jun 23, 2014
Greetings to Dimension and Bayer for their fresh start.
I wish both of you will get success in this GENE therapy and helps lakhs of patient who daily pray for long term treatment.
Wish you a successful soon.
Add your comments below
|Eaton, US Department of Energy to Enhance Colla...||Jan 15||Solarman||1|
|IAC's future in limbo (Jun '07)||Dec '17||dylan f||69|
|Professors worldwide boycott University of Roch...||Nov '17||Mrs L||4|
|New Andon software||Nov '17||nateandon||1|
|Goodyear Tire recalls Eagle RS-A 18" TIRES (Feb '09)||Oct '17||Daniel||14|
|Can manufactures use W.O.T.C. ?||Oct '17||Larry Potter||1|
|headstone manufacturers||Oct '17||Andymolly||1|
Find what you want!
Search Manufacturing Forum Now
Copyright © 2018 Topix LLC